PHARMACEUTICAL COMPOSITIONS COMPRISING LEVODOPA, A DOPAMINE DECARBOXYLASE INHIBITOR AND A COMT INHIBITOR AND METHOD OF ADMINISTRATION THEREOF
- 专利权人:
- LobSor Pharmaceuticals Aktiebolag
- 发明人:
- Roger Bolsöy
- 申请号：
- US16054392
- 公开号：
- US20180338944A1
- 申请日:
- 2018.08.03
- 申请国别(地区):
- US
- 年份:
- 2018
- 代理人:
- 摘要：
- A pharmaceutical gel composition for intra-intestinal administration comprises (i) a dopamine replacement agents, (ii) a dopamine decarboxylase inhibitor (DDI), and (iii) a COMT inhibitor.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Pharmaceutical compositions comprising levodopa, a dopamine decarboxylase inhibitor and a COMT inhibitor and method of administration thereof
- Pharmaceutical compositions comprising levodopa, a dopamine decarboxylase inhibitor and a COMT inhibitor and method of administration thereof
- Pharmaceutical composition comprising levodopa, dopamine decarboxylase inhibitor and COMT inhibitor and method of administration thereof
- Pharmaceutical compositions comprising levodopa, a dopamine decarboxylase inhibitor and a COMT inhibitor and method of administration thereof
- PHARMACEUTICAL COMPOSITIONS COMPRISING LEVODOPA, A DOPAMINE DECARBOXYLASE INHIBITOR AND A COMT INHIBITOR AND METHOD OF ADMINISTRATION THEREOF
